Medical Education Library

Managing Atopic Dermatitis in Children: The Role of Newer Nonsteroidal Topical Treatments


A supplement to Skin & Allergy News and supported by Ferndale Laboratories. The articles in this supplement are based on faculty interviews.


To view the supplement, click the image above.

Faculty/Faculty Disclosure

Leon H. Kircik, MD
Associate Clinical Professor of Dermatology
Indiana University Medical Center
Medical Director
DermResearch, PLLC
Louisville, Ky
Dr. Kircik has disclosed that he has received research support from, is a consultant to, and is on the speaker's bureau for 3M Pharmaceuticals, Abbott Laboratories, Acambis, Allergan Inc., Amgen Inc., Astellas, Bayer HealthCare Pharmaceuticals, Biogen-Idec, Biolife, LLC, Breckenridge Pharmaceutical, Inc., Centocor, Inc., CollaGenex Pharmaceuticals Inc., CombiMatrix, Coria Laboratories, Ltd., Dermik Laboratories, The Dow Chemical Company, Ferndale Laboratories, Inc., Galderma Laboratories, L.P., Genentech, Inc., GlaxoSmithKline, Healthpoint, Ltd., Intendis, Medicis Pharmaceutical Corporation, Merck Serono, NanoBio Corporation, Novartis Pharmaceuticals Corporation, NUCRYST Pharmaceuticals Corp., OrthoNeutrogena, QLT Inc., Quatrix, SkinMedica, Inc., Stiefel Laboratories, Inc., ToleRx, Inc., Valeant Pharmaceuticals International, and Warner-Chilcott.

Poster Review
* Patient Demographics and Baseline Characteristics
* Clinical Assessments
* Safety Evaluation
* Results
* Adverse Events
* Summary by Dr. Kircik

Copyright © 2007 Elsevier Inc.

Next Article: